AssessmentExecutive Assessment
 
       
Executive Team
 

Iyabode Akinsanya-Beysolow,
MD, MPH


Paul G. Auwaerter,
MD, MBA, FACP, FIDSA

John G. Bartlett,
MD

Todd T. Brown,
MD, Phd


Michael A. Chattergoon,
MD, PhD


Joseph Cofrancesco Jr.,
MD, MPH, FACP


Calvin J. Cohen,
MD, MSc


Sara E. Cosgrove,
MD, MS


Thomas Donner,
MD, (planning committee)


Joel E. Gallant,
MD, MPH


Amita Gupta,
MD, MHS


Lawrence Herman,
MPA, RPA-C, DFAAPA


Charles Hicks,
MD


Christopher Hoffmann,
MD, MPH


Rita Rastogi Kalyani,
MD, MHS


Rebecca A. Kazin,
MD


Gregory M. Lucas,
MD, PhD


David H. Madoff,
MD, PhD


Kieren A. Marr,
MD


Nisa M. Maruthur,
MD, MHS


Nestoras Mathioudakis,
MD


Michael Melia,
MD


Dionissios Neofytos,
MD, MPH


Eric Nuermberger,
MD


Kathleen R. Page,
MD


Trish M. Perl,
MD, MSc


Paul A. Pham,
PharmD


Richard E. Rothman,
MD, PhD, FACEP


Paul E. Sax,
MD


Mark S. Sulkowski,
MD


Aimee K. Zaas,
MD, MHS





 

Title: "Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections Part 2”

Presented by: The Johns Hopkins University School of Medicine

Release Date: June 30, 2014
Expiration Date: June 6, 2015

Estimated time to complete each part of this activity:
30 minutes. This activity has been approved for a maximum of 0.50 AMA PRA Category 1 Credit(TM). There are no fees or prerequisites.

Acknowledgement of Commercial Support: Supported by independent educational grants from Abbvie, Inc. and Merck.

 

Executive Team
“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections Part 2”
This activity has been approved for 0.5 AMA PRA Category 1 Credits™.

“Highlights from the 2014 Conference on Retroviruses and Opportunistic Infections Part 1”
This activity has been approved for 0.5 AMA PRA Category 1 Credits™.